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Introduction
Ischemic stroke is defined as an episode of neurological dysfunction caused by focal cerebral, spinal or retinal infarction accompanied by overt symptoms. 1 About 90% of all strokes are ischemic, while roughly 10% are hemorrhagic (including intracerebral and subarachnoid hemorrhage). 2 Patients presenting signs and symptoms of acute ischemic stroke (AIS) undergo a series of CT imaging procedures, including non-contrast CT to exclude pre-treatment intracranial hemorrhage, CT angiography (CTA) to determine the precise location of vessel occlusion, CT perfusion (CTP) to differentiate between potentially salvageable and irreversibly damaged brain tissue, and post-treatment non-contrast CT to exclude thrombolysisrelated hemorrhage. [3] [4] [5] [6] The standard AIS treatment method within 4.5 hours of symptom onset is intravenous thrombolysis (IVT) with tissue plasminogen activator (tPA) injection. 7, 8 Patients with IVT-therapy contraindications or ineffectiveness may be eligible for endovascular mechanical thrombectomy (MT). 8, 9 Hemorrhagic transformation (HT) is a conversion of ischemic brain tissue into a hemorrhagic lesion due to blood-brain barrier disruption. It may occur spontaneously in ischemic brain tissue but may also be triggered by reperfusion. 10, 11 HT occurs in 4.5 -68.0% of AIS clinical cases and has a higher incidence in patients treated with IVT than in patients without such treatment. [12] [13] [14] While mild to moderate HT may not seriously impact the clinical outcome, severe HT is a significant predictor of neurological deterioration and higher mortality. 14, 15 CTP is an imaging technique that measures brain tissue blood perfusion by analyzing time-attenuation curves of contrast agent in input artery and parenchyma, generating maps of CT perfusion parameters (CTPPs). CTPPs are cerebral blood volume (CBV), mean transit time (MTT) and cerebral blood flow (CBF). CBV is defined as the total volume of flowing blood in a given volume of brain. MTT is defined as the average transit time of blood through a given brain region. CBF is defined as the volume of flowing blood moving through a given volume of brain in a specific amount of time. The three CTPPs are associated by the equation: CBF = CBV / MTT. Previous studies have shown that CTPPs of the whole infarct area (penumbra and infarct core as a single region) could be used to predict HT, finding relative CBV (rCBV) ≤ 1.09 and T max > 14 s , respectively, to be the most predictive of HT, with relative CBF (rCBF) < 30% also being of considerable utility in predicting HT. 18, 19 One study found neither CBF nor CBV to be significantly different between cases and controls, while not examining relative CTPPs. 20 Another study examined infarct-core CTPPs, finding CBV ≤ 0.5 mL/100 g to be predictive of symptomatic intra-cerebral hemorrhage, while also not investigating relative CTPPs. 21 One study initially proposed separate analysis of infarct-core CTPPs but eventually dismissed the idea due to insufficient sample size. 18 The rationale for separate analysis of the infarct core subregion is that it may provide a different insight into HT prediction than a whole-infarct approach, due to the elimination of the "averageout" effect. 21 The reasoning behind the use of relative rather than absolute CTPPs is to account for potential interpatient variability, while also avoiding the inter-vendor variability of postprocessing software. 18, 22 Our study thus aimed to investigate CTPPs of the infarct core in predicting HT, with an emphasis on relative CTPPs
Patients and methods

Patients
This single-centre retrospective study enrolled 75 patients (47 males, 37 females, mean age ± SD 72.63 ± 11.7 years) who had been admitted to neurological emergency, with AIS symptoms lasting less than 4.5 hours. Patients underwent admission non-contrast CT, CTA and CTP imaging, and were treated with IVT according to guidelines, in the period from January 2012 -April 2015. The study was performed in accordance with the Declaration of Helsinki and was approved by the National Medical Ethics Committee (Trial registration number: 0120-453/2017-3).
Methods
CT, CTA and CTP imaging were performed with a Siemens Sensation Open 40 (Siemens Medical Systems, Erlangen, Germany). CTP was performed using 40 mL of iodinated contrast medium at a flow rate of 6 mL/s, followed by 40 mL of saline flush at the same rate, injected into the cubital vein. Four s after initiation of the injection, a continuous (cine) scan was initiated using the following parameters: 80 kVp, 209 mAs, 4 × 5 mm sections, 1-second per rotation for a duration of 40 s. The images were loaded onto a workstation (Syngo MultiModality Workplace; Siemens Healthcare, Erlangen, Germany). CTPPs -cerebral blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT) -were automatically calculated from CTP data using commercial software (Neuro PCT; Siemens Healthcare, Erlangen, Germany). A single circular region of interest (ROI) measuring 15-20 mm in diameter was placed in the region of the infarct core. Mirror ROI was automatically placed by the software in the contralateral (i.e., asymptomatic) hemisphere. Region-specific CTPPs of both ROIs were measured. Relative CTPPs were calculated by dividing the CTPP values of infarct core ROI by asymptomatic hemisphere ROI.
The development of HT was documented by follow-up non-contrast CT 24 h after initial imaging. Patients who developed HT were assigned to the cases group (n=35), while patients that did not develop HT were assigned to the controls group (n=40), matching the cases based on time from AIS symptom onset to IVT ± 0.5 h. The matching was carried out by first obtaining the data regarding the time period from AIS symptom onset to the start of the IVT procedure for each patient, then selecting those patients from the pool of controls group candidates that most closely matched each cases group patient's time period, ± 0.5 h being the cutoff point beyond which a controls group candidate would not be considered for matching. Adhering to these conditions 40 cases were assigned controls, however due to technical inadequacies of some of the imaging studies (e.g. patient movement) cases group was later reduced to 35 patients.
Statistical analysis
All numerical data were reported as means ± standard deviation. The normality of data distribution was evaluated by the Shapiro-Wilk test. The Mann-Whitney U-test was used to determine the existence of a statistically significant difference in CTPPs between cases and controls. A p value < 0.05 was regarded as statistically significant. The area of the receiver operating characteristic (ROC) curve under the curve (AUC) determined the ability of CTPPs to differentiate between the occurrence and non-occurrence of HT. ROC curve analysis identified optimal cut-off values of CTPPs that predict the onset of HT with the highest sensitivity and specificity. IBM SPSS Statistics (version 20.0, SPSS Inc., Chicago, IL, USA) was used to perform statistical analyses.
Results
Seventy-five patients with AIS who had undergone CTP imaging and had been treated with IVT were included in the study. Significant differences in mean values between cases and controls were observed (p = < 0.000-0.009) for CBF, CBV, rCBF and rCBV.
The area under the curve (AUC) of the receiver operating characteristic (ROC) of rCBF (0.736) showed a satisfactory ability to differentiate between the occurrence and non-occurrence of HT, while AUCs of CBF, CBV and rCBV showed comparatively inferior differentiation abilities (0.704-0.676).
Discussion
HT is a potentially grave complication of IVT, occurring in 4.5-68.0% of clinical AIS cases. Severe HT is a significant predictor of neurological deterioration and higher mortality. 15 Various HT prediction methods have been investigated, including CT, CTP, SPECT and diffusion-and perfusionweighted MR imaging. [21] [22] [23] [24] [25] [26] According to previously published data, CTPPs of the whole infarct area effectively predict HT. Jain et al. and Yassi et al. found relative CTPPs -rCBV and rCBF, respectively, -to be the most predictive of HT. 18, 19 To the best of our knowledge, this study is the first to analyze relative CTPPs of infarct core in predicting HT. On the one hand, the infarct core itself seems not to have been the main focal point of investigations so far, due to various circumstances, including limited sample size, as was the case with Jain et al. 18 On the other hand, the sole study that did analyze infarct core, carried out by Lin et al., investigated absolute CTPPs only. The findings of Zussman et al. cautioned against using absolute CTPPs due to inter-vendor variability of postprocessing software, while Jain et al. also warned of possible interpatient variability of absolute CTPPs, encouraging the use of relative CTPPs instead. 21, 22 The above arguments prompted us to focus on analyzing relative CTPPs of the infarct core, with the full knowledge that there might currently be no point of reference to compare our results directly. We found additional reasoning for an infarct-core approach in the fact that our attempts at free-hand whole-infarct designation with image segmentation to eliminate structures that were irrelevant for CTP (e.g., large vessels and sulci) proved futile in many cases; eliminating a large vessel completely often required such a large Hounsfield units (HU) exclusion interval that it inadvertently also deselected the majority of tissue viable for CTP analysis. Additionally, we found the non-segmentation single-ROI infarct-core approach to be fast and straightforward -a potential advantage when using CTPPs in an emergency clinical setting.
Our study of infarct-core CTPPs demonstrates that rCBF < 4.5% of the contralateral mean best predicts the occurrence of HT (sensitivity 71.0%, specificity 52.5%). Considering studies that opted for whole-infarct measurement of relative CTPPs, it should be noted that our approach offered considerably inferior sensitivity but better specificity than whole-infarct rCBF < 30% (sensitivity 100%, specificity 39.0%) studied by Yassi et al., while whole-infarct rCBV < 1.09 (sensitivity 100%, specificity 58.3%) researched by Jain et al. proved to be superior to both infarct-core rCBF and wholeinfarct rCBF. Infarct-core rCBV < 8.5% (sensitivity 71.4%, specificity 42.5%) examined by our study proved to be inferior in HT prediction to the aforementioned CTPPs but might be considered as an additional parameter to rCBF when evaluating the infarct core due to similar sensitivity. A possible reason for the extremely low infarctcore rCBF examined in our study being less sensitive in prediction of HT than the moderately low whole-infarct rCBF examined by Yassi et al. might be that the severe hypo-perfused stroke region contains very low levels of contrast, which in certain cases could be undetectable by CTP. 19 Additionally, our ROI placement protocol limited the maximum diameter of circular ROI to 20 mm, and while smaller ROIs help eliminate the "average-out" effect that is associated with large, whole-infarct freehand ROIs, they may also be more susceptible to the effect of random pixel noise. 21 Another possible source of the comparatively higher data heterogeneity in our study may be the potential temporal truncation of the contrast bolus in the infarct region. 27, 28 Our study has several limitations. It was a retrospective study. The effects of stroke severity and anatomical location were not controlled by matching, nor was the anatomical location of HT. HT was not stratified into subtypes. The time to treatment was controlled by matching; this, however, decreased the final cohort size. ROI placement was performed by a single experienced operator but no estimation of the intra-observer reproducibility of this procedure was made. Our results represent only a single-institution experience.
In conclusion, our analysis indicates that infarctcore CTPPs -low rCBF in particular -can predict HT in patients with AIS. Should this be further verified by larger multi-centre studies, CTP imaging could become the method of choice for identification of patients at low risk of HT, thus helping decide on IVT treatment.
